| abstract |
The present invention relates to methods of treating cancer in humans and pharmaceutical combinations useful for such treatment. In particular, this method comprises proteasome inhibitor compounds and N-{(1S) -2-amino-1-[(3-fluorophenyl) methyl] ethyl} -5-chloro-4- (4-chloro-1-methyl -1H-pyrazol-5-yl) -2-thiophene-carboxamide, or a pharmaceutically acceptable salt thereof, and an additional antineoplastic agent that may be used, to a human in need thereof And a method for treating cancer. |